SAB Biotherapeutics, Inc. (SABS): 4 filed Sep 18, 2026

Form type
4
Filing date
Sep 18, 2026
Accession number
0001193125-26-395552
Filer
SAB Biotherapeutics, Inc. (CIK 1833214)